6505--Naproxen Tablets 8-1-2026 - 7-31-2027

The Department of Veterans Affairs National Acquisition Center plans to issue a Request for Proposal (RFP 36E79726R0011) for the procurement of Naproxen Tablets to serve the VA, Department of Defense, Bureau of Prisons, and Indian Health Service. This contract aims to establish a one-year base period with four additional one-year option periods to ensure a continuous supply of Naproxen tablets. The contract will involve distribution through the VA Pharmaceutical Prime Vendor Programs. Offerors are required to provide the exact drug name as it appears on the label and must supply products with unique NDC or UPC codes. The solicitation will be issued electronically in commercial item format around February 10, 2026, with responses due by February 24, 2026. All solicitation materials and amendments will be available solely through the government procurement website, and interested vendors must monitor it for updates. The estimated annual quantities for the contract include various strengths and bottle sizes of Naproxen tablets, ranging from 250 mg to 500 mg, in 100-tablet and 500-tablet bottles. The largest volume is for the 500 mg tablets in 500-count bottles, with an estimated annual requirement exceeding 115,000 bottles. The North American Industry Classification System (NAICS) code for this procurement is 325412, identifying the pharmaceutical manufacturing sector. The contracting point of contact is Michael Olszewski, who can be reached via email for questions related to the solicitation. This procurement seeks responsible sources capable of providing an uninterrupted supply to meet the comprehensive pharmaceutical needs of several federal health entities.